Lapatinib 250 Mg Tablet

Get a Price/Quote

MOQ : 100 Boxes

Lapatinib 250 Mg Tablet Specification

Indication
Treatment of breast cancer (specifically HER2-positive breast cancer)

Dosage Form
Tablet

Salt Composition
Lapatinib 250 mg

Feature
For oral use

Application
Oncology (anticancer therapy)

Physical Color/Texture
Tablet, typically film-coated

Storage Instructions
Store below 30C, keep in a dry place, protect from light

Shelf Life
24-36 months (vary by manufacturer)

Type of Medicine
Antineoplastic Agent / Tyrosine Kinase Inhibitor

Brand Name
LANIB 250

Packaging Size
30 Tablets per pack

Intended Patient
Adult females with HER2-positive breast cancer

Route of Administration
Oral

Usage Instructions
As directed by physician

Strength
250 mg per tablet

Prescription
Prescription only

Lapatinib 250 Mg Tablet Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Lapatinib 250 Mg Tablet About

Experience elite cancer care with LANIB 250, the potent Lapatinib 250 mg Tablets crafted for adult females battling HER2-positive breast cancer. This top-notch antineoplastic agent, a kingly choice in oncology, is prescribed strictly by physicians. Administered orally, each film-coated tablet delivers precision therapy and reliable absorption. Packaged in 30-tablet packs and ideally stored below 30C, LANIB 250 offers a robust, long shelf life (24-36 months). Grab yours today and try now for exceptional efficacy and trusted cancer management.

LANIB 250: A Superior Oncology Solution

LANIB 250 stands out due to its advanced tyrosine kinase inhibition, targeting HER2-positive breast cancer effectively. Crafted using top-grade materials, these film-coated tablets demonstrate excellent stability and consistent potency. Suitable for use in oncology departments and clinics, its competitive advantage lies in both efficacy and premium formulation. Patients and clinicians recognize LANIB 250 as a reliable oral antineoplastic, making it a preferred treatment option in cancer care.

LANIB 250 Sample Policy and Global Reach

LANIB 250 offers flexible sample policies to support informed purchasing decisions. Quotations are promptly generated upon request, and samples can be provided for evaluation under standard terms. Our main export markets include Asia, the Middle East, and Africa, ensuring that delivery and drop-off schedules remain swift and reliable. With a streamlined supply chain, we prioritize timely product availability to all our global clients, facilitating rapid responses and continuous support for healthcare providers.

FAQ's of Lapatinib 250 Mg Tablet:

Q: How should LANIB 250 be stored to maintain its effectiveness?

A: LANIB 250 should be stored below 30C, in a dry place, and protected from light to maintain potency and shelf life.

Q: What is the primary benefit of using LANIB 250 for eligible patients?

A: LANIB 250 is designed for adult females with HER2-positive breast cancer, offering targeted therapy that inhibits cancer cell growth effectively.

Q: When should LANIB 250 be taken, and who should prescribe it?

A: LANIB 250 must only be used under the direction of a qualified physician, following precise prescription guidelines tailored to the patient.

Q: Where can LANIB 250 be sourced for treatment purposes?

A: LANIB 250 is manufactured, supplied, and traded primarily within India but is also available internationally through approved dealers and healthcare providers.

Q: What is the recommended process for obtaining a quotation and sample of LANIB 250?

A: To obtain a quotation or request a sample, healthcare providers can contact the manufacturer or authorized supplier directly, who will guide them through the necessary request and delivery procedures.

Tell us about your requirement